- Home
- HOG vs MANE Comparison
HOG vs MANE Comparison
Compare HOG & MANE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HOG | MANE |
|---|---|---|
| Founded | 1903 | 2019 |
| Country | United States | United States |
| Employees | 6400 | N/A |
| Industry | Motor Vehicles | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.8B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | HOG | MANE |
|---|---|---|
| Price | $19.52 | $65.49 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 4 |
| Target Price | $24.88 | ★ $78.33 |
| AVG Volume (30 Days) | ★ 3.6M | 303.8K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.69% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.78 | N/A |
| Revenue | ★ $4,473,175,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.34 | N/A |
| P/E Ratio | $7.01 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $17.09 | $36.26 |
| 52 Week High | $31.25 | $69.41 |
Technical Indicators
Market Signals| Indicator | HOG | MANE |
|---|---|---|
| Relative Strength Index (RSI) | 56.38 | 77.60 |
| Support Level | $17.10 | $39.73 |
| Resistance Level | $19.63 | N/A |
| Average True Range (ATR) | 0.71 | 4.67 |
| MACD | 0.24 | 0.99 |
| Stochastic Oscillator | 87.07 | 87.70 |
Price Performance
Historical ComparisonAbout HOG Harley-Davidson Inc.
Harley-Davidson is a leading global manufacturer of heavyweight motorcycles across the custom, cruising, and touring categories, as well as related merchandise, parts, and accessories. In recent years, the firm has expanded into the adventure touring market with its Pan America model and into electric with the LiveWire brand. Its captive finance arm, Harley-Davidson Financial Services, provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley captured around 34% of the heavyweight domestic market in 2025.
About MANE Veradermics Incorporated Common Stock
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.